Abstract:During excitotoxicity, reactive oxygen species, produced by NADPH‐oxidase 2 (NOX‐2), increases the levels of aquaporin‐4 (AQP4) leading to the rupture of the blood–brain barrier and cerebral edema. This along with oxidative stress contributes to neuronal death. Stimulation of cannabinoid receptor type 1 receptors relieves oxidative stress by a reduction of NOX‐2 activity and thus inhibits AQP4 increase, edema, and brain damage. The endocannabinoid system can be a therapeutic target for limiting brain damage. Background Excitotoxicity is a process in which NADPH oxidase‐2 (NOX‐2) plays a pivotal role in the generation of reactive oxygen species (ROS). Oxidative stress influences the expression of Aquaporin 4 (AQP4), a water channel implicated in blood–brain barrier (BBB) permeability and edema formation. The endocannabinoid system is widely distributed in the brain, particularly through the cannabinoid receptor type 1 (CB1) and type 2 (CB2), which have been shown to have a neuroprotective function in brain injury. Given the significant involvement of NOX‐2 in ROS production during excitotoxicity, our research aims to assess the participation of NOX‐2 in the neuroprotective effect of the cannabinoid receptor agonist WIN55,212‐2 against glutamate‐induced excitotoxicity damage in the striatum using in vivo model. Methods Wild‐type mice (C57BL/6) and NOX‐2 KO (gp91Cybbtm1Din/J) were stereotactically injected in the striatum with monosodium glutamate or vehicle. Subsequently, a group of mice was administered an intraperitoneal dose of WIN55,212‐2, AM251, or AM251/WIN55,212‐2 following the intracerebral injection. Motor activity was assessed, and the lesion was examined through histological sections stained with cresyl violet. Additionally, brain water content and Evans blue assay were conducted. The activity of NOX was quantified, and the protein expression of CB1, gp91phox, AQP4, Iba‐1, TNF‐α, and NF‐κB was analyzed using Western blot. Furthermore, ROS formation was measured through the DHE assay. Results The activation of the endocannabinoid receptors demonstrated a neuroprotective response during excitotoxicity, meditated by NOX‐2. The reduction in ROS production led to a decrease in neuroinflammation, and AQP4 expression, resulting in reduced edema formation, and BBB permeability. Conclusions During excitotoxic damage, WIN55,212‐2 inhibits NOX‐2‐induced ROS production, reducing brain injury.

Neuroprotective Effects of Cannabispirenone A against NMDA-Induced Excitotoxicity in Differentiated N2a Cells

Mesoporous Silica Particles As a Multifunctional Delivery System for Pain Relief in Experimental Neuropathy.

Intracellular Molecular Targets and Signaling Pathways Involved in Antioxidative and Neuroprotective Effects of Cannabinoids in Neurodegenerative Conditions

Cytisine Confers Neuronal Protection Against Excitotoxic Injury by Down-Regulating GluN2B-containing NMDA Receptors.

Neuroprotection of Cannabidiol, Its Synthetic Derivatives and Combination Preparations against Microglia-Mediated Neuroinflammation in Neurological Disorders

Neuroprotective Effects of Curculigoside Against NMDA-induced Neuronal Excitoxicity in Vitro

Anandamide and WIN 55212–2 Afford Protection in Rat Brain Mitochondria in a Toxic Model Induced by 3-Nitropropionic Acid: an In Vitro Study

CB1 Receptor Activation Provides Neuroprotection in an Animal Model of Glutamate‐Induced Excitotoxicity Through a Reduction of NOX‐2 Activity and Oxidative Stress

A Comparative In Vitro Study of the Neuroprotective Effect Induced by Cannabidiol, Cannabigerol, and Their Respective Acid Forms: Relevance of the 5-HT1A Receptors

Evaluation of the efficacy of a full-spectrum medicinal cannabis plant extract with less than 0.3% Δ9-tetrahydrocannabinol in models of inflammation and excitotoxicity

Inhibition of Mitochondrial Permeability Transition Pore Opening Contributes to Cannabinoid Type 1 Receptor Agonist ACEA-induced Neuroprotection

High Concentrations of Cannabidiol Induce Neurotoxicity in Neurosphere Culture System

A novel insight into the neuroprotective effects ofcannabidiol: maintained apelin/dopamine synthesis, NRF2 signaling, and AKT/CREB/BDNF gene expressions

Nobiletin as a Neuroprotectant against NMDA Receptors: An In Silico Approach

Cannabidiol Confers Neuroprotection in Rats in a Model of Transient Global Cerebral Ischemia: Impact of Hippocampal Synaptic Neuroplasticity

Cannabinoids and neuronal damage: differential effects of THC, AEA and 2-AG on activated microglial cells and degenerating neurons in excitotoxically lesioned rat organotypic hippocampal slice cultures

Investigation of neuroprotective and therapeutic effects of cannabidiol in an acute coronary syndrome model

Medicinal cannabis extracts are neuroprotective against Aβ1-42-mediated toxicity in vitro

Neuroprotective effects of anandamide and its analogs

The Neurotherapeutic Arsenal in Cannabis sativa: Insights into Anti-Neuroinflammatory and Neuroprotective Activity and Potential Entourage Effects

Neuroprotection and Beyond: The Central Role of CB1 and CB2 Receptors in Stroke Recovery